CGB — Cann Global Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Cann Global, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
| 2018 June 30th | 2019 June 30th | 2020 June 30th | C2021 June 30th | 2022 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS | 
| Status: | Final | Final | Final | Final | Final | 
| Revenue | |||||
| Total Revenue | 3.87 | 0.604 | 1.93 | 1.49 | 0.562 | 
| Cost of Revenue | |||||
| Gross Profit | 3.67 | 0.042 | 0.618 | 0.326 | -0.078 | 
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 8.14 | 8.93 | 7.97 | 6.32 | 9.8 | 
| Operating Profit | -4.26 | -8.32 | -6.04 | -4.83 | -9.24 | 
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -4.71 | -9.23 | -8.05 | -4.77 | -9.08 | 
| Provision for Income Taxes | |||||
| Net Income After Taxes | -5 | -9.23 | -8.05 | -4.77 | -9.08 | 
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -5.44 | -6.43 | -8.01 | -4.62 | -8.22 | 
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5.44 | -6.43 | -8.01 | -4.62 | -8.22 | 
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.07 | -0.1 | -0.064 | -0.024 | -0.014 |